Cargando…
Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) is an incurable genetic disease characterized by degeneration and necrosis of myofibers, chronic inflammation, and progressive muscle weakness resulting in premature mortality. Immunosuppressive multipotent mesenchymal stromal cell (MSC) therapy could be...
Autores principales: | Nitahara-Kasahara, Yuko, Nakayama, Soya, Kimura, Koichi, Yamaguchi, Sho, Kakiuchi, Yuko, Nito, Chikako, Hayashi, Masahiro, Nakaishi, Tomoyuki, Ueda, Yasuyoshi, Okada, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142496/ https://www.ncbi.nlm.nih.gov/pubmed/37106393 http://dx.doi.org/10.1186/s13287-023-03337-0 |
Ejemplares similares
-
Inflammatory predisposition predicts disease phenotypes in muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2016) -
Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2021) -
Dental-Pulp Stem Cells as a Therapeutic Strategy for Ischemic Stroke
por: Nito, Chikako, et al.
Publicado: (2022) -
Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation
por: Tago, Yoshiyuki, et al.
Publicado: (2021) -
Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2021)